Clinical Trials Market is estimated to be US$ 14.36 billion by 2030 with a CAGR of 5.3% during the forecast period prophecymarketinsights.com

The report "Global Clinical Trials Market, By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional Trials, Observational Trials, and Expanded Access Trials), By Indication (Autoimmune, Blood Disorders, Cancer, Circulatory, CNS, Congenital, CVS, Dermatology, Ear, Gastrointestinal, Genitourinary, Infections, Mental Disorders, Metabolic, Musculoskeletal, Nose, Ophthalmology and Others), and, By Region (North America, Asia Pacific, Europe, Latin America and Middle East & Africa)-Trends, Analysis and Forecast till 2030’’